The Anthem Biosciences Limited IPO date has been confirmed from July 14, 2025, and closes on July 16 2025. Read the post to learn about Anthem Biosciences Limited IPO GMP.
Anthem Biosciences IPO is a book building of ₹3,395.00 crores. The issue is entirely an offer for sale of 5.96 crore shares. Anthem Biosciences IPO price band is set at ₹540 to ₹570 per share. The lot size for an application is 26. The minimum amount of investment required by an retail is ₹14,040 (26 shares). The lot size investment for sNII is 14 lots (364 shares), amounting to ₹2,07,480, and for bNII, it is 68 lots (1,768 shares), amounting to ₹10,07,760.
Start your investing journey today. How do you open your own demat account for free?
Bidding Dates
July 14-16
Price Range
₹540 to ₹570 per share
Face Value
₹2 per share
GMP
₹104
Anthem Biosciences Limited IPO GMP
The Anthem Biosciences Limited IPO GMP Today is ₹104.
IPO Overview
Anthem Biosciences IPO opens for subscription on July 14, 2025 and closes on July 16, 2025. The allotment for the Anthem Biosciences IPO is expected to be finalized on Thursday, July 17, 2025. Anthem Biosciences IPO will be list on BSE, NSE with a tentative listing date fixed as Monday, July 21, 2025.
Anthem Biosciences Limited IPO Details
| IPO Date | July 14, 2025 to July 16, 2025 |
| Listing Date | [.] |
| Face Value | ₹2 per share |
| Issue Price Band | ₹540 to ₹570 per share |
| Lot Size | 26 Shares |
| Sale Type | Offer For Sale |
| Total Issue Size | 5,95,61,404 shares (aggregating up to ₹3,395.00 Cr) |
| Employee Discount | ₹50.00 |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE, NSE |
| Share Holding Pre Issue | 55,90,77,100 shares |
| Share Holding Post Issue | 55,90,77,100 shares |
Anthem Biosciences Limited Financial Information
| Period Ended | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
| Assets | 2,807.58 | 2,398.11 | 2,014.46 |
| Revenue | 1,930.29 | 1,483.07 | 1,133.99 |
| Profit After Tax | 451.26 | 367.31 | 385.19 |
| EBITDA | 683.78 | 519.96 | 446.05 |
| Net Worth | 2,409.86 | 1,924.66 | 1,740.67 |
| Reserves and Surplus | 2,298.05 | 1,815.39 | 1,628.88 |
| Total Borrowing | 108.95 | 232.53 | 125.06 |
| Amount in ₹ Crore | |||
Anthem Biosciences Limited IPO Timeline
| IPO Open Date | Mon, Jul 14, 2025 |
| IPO Close Date | Wed, Jul 16, 2025 |
| Tentative Allotment | Thu, Jul 17, 2025 |
| Initiation of Refunds | Fri, Jul 18, 2025 |
| Credit of Shares to Demat | Fri, Jul 18, 2025 |
| Tentative Listing Date | Mon, Jul 21, 2025 |
| Cut-off time for UPI mandate confirmation | 5 PM on July 16, 2025 |
Company Profile
Anthem Biosciences is a leading Contract Research and Innovation Service Provider (CRISP) based in Bangalore, India, equipped to support end-to-end drug discovery, development, and manufacturing. With over 1000 researchers and world-class infrastructure, Anthem excels in both chemical and biological domains, offering solutions for small molecules, proteins, monoclonal antibodies, peptides, and more. The company provides a broad spectrum of services, including safety and efficacy testing, preclinical studies in GLP facilities, Antibody Drug Conjugates (ADCs), and high-potency compound development. Backed by USFDA, PMDA, and EU QP approvals, Anthem also delivers robust GMP manufacturing capabilities — from milligrams to multi-ton scale — and advanced analytical, QC, and regulatory support. With a strong scientific foundation, Anthem extends its expertise to nutraceutical innovation, helping global clients bring products from concept to commercialization with quality and precision.
Registrar Info
| Name | Kfin Technologies Limited |
| Phone number | 04067162222, 04079611000 |
| Email ID | anthem.ipo@kfintech.com |
| Website | https://kosmic.kfintech.com/ipostatus/ |
Contact Details
| Name | Anthem Biosciences Limited |
| Phone number | +91 080 6672 400 |
| Email ID | investors.abl@anthembio.com |
| Website | https://www.anthembio.com/ |
IPO Strenghts
- Experienced promoters and a competent management team.
- Well-established relationships with a loyal customer base.
- Access to markets worldwide, enabling global reach.
IPO Weakness
- Heavy reliance on customers based in the United States.
- Need to adhere to multiple laws and regulations in these countries to ensure compliance.
- Competition from other players in the market.
Anthem Biosciences Limited IPO FAQs
When Anthem Biosciences IPO will open?
The Anthem Biosciences IPO opens on July 14, 2025 and closes on July 16, 2025.
What is the lot size of Anthem Biosciences IPO?
Anthem Biosciences IPO lot size is 26, and the minimum amount required for application is ₹14,820.
When is Anthem Biosciences IPO listing date?
The Anthem Biosciences IPO listing date is not yet announced. The tentative date of Anthem Biosciences IPO listing is Monday, July 21, 2025.
Leave a Reply